Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
11/2003
11/05/2003CN1126755C Process for preparing N-[5-(diphenyl phosphinyl methyl)-4-(4-fluoropheyl)-6-isopropyl pyrimidine-2-group]-N-methl methane sulfamide
11/05/2003CN1126753C Pyrazolo (3,4-D) pyrimidines for anticonvulsive and antialiergic/antiasthmatic action
11/05/2003CN1126743C Substituted quinazoline derivatives
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003US6642242 Quinoline and quinazoline compounds useful in therapy
11/04/2003US6641871 Electrooptical display
11/04/2003CA2290709C 2,6-diaminopyridine compounds as intermediates for producing antibacterial dihydropyridone carboxylic acid derivatives
11/04/2003CA2232728C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
10/2003
10/30/2003WO2003089416A1 Substituted pyrimidine-2,4(1h,3h)-diones for use as matrix metalloproteinase (mmp) inhibitors
10/30/2003WO2003088972A1 Novel compounds
10/30/2003WO2003088917A2 Regulation of tnf-alpha
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
10/30/2003WO2001097615A9 Herbicidal agent
10/30/2003US20030204085 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists
10/30/2003US20030203926 For treatment of inflammatory or autoimmune condition, viral infection, cancer
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/30/2003CA2482022A1 Novel compounds
10/29/2003EP1357114A1 Substituted pyrimidin-2,4(1H,3H)-diones as inhibitors of Matrix Metalloproteinases (MMP)
10/29/2003EP1357113A1 6-(1-fluoroethyl)-5-iodo-4-aminopyrimidine compounds, process for preparation of the same, and pest controllers for agricultural and horticultural use
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1355887A1 Pyrimidine acyclonucleoside derivatives, preparation method and use thereof
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1355645A2 Method for treating fibrotic diseases or other indications iiic
10/29/2003EP1153920B1 Quinoline derivatives and quinazoline derivatives
10/29/2003EP1150964B1 Polycyclic pyrimidine-2,4(1h, 3h)-dione with functionalized alkyl radicals in 1- and/or 3-position, method for the production thereof and pharmaceutical preparations
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003CN1452627A 3'-prodrugs of 2'-deoxy-beta-L-nucleosides
10/29/2003CN1125817C Quinazoline derivatives as VEGF inhibitors
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/28/2003US6638947 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/28/2003US6638939 6,7-dimethoxyquinazolines and therapeutic use thereof
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003CA2040423C Fluorobenzene derivatives and liquid-crystalline medium
10/23/2003WO2003087112A1 Chiral intermediate and process for the production thereof
10/23/2003WO2003087067A1 Aryl-alkyne compounds as herbicides
10/23/2003WO2003087065A1 Inhibitors of glycinamide ribonucleotide transformylase
10/23/2003WO2003087064A1 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2003087044A2 Novel carboxamide compounds for use in mch receptor related disorders
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003086398A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003WO2003086282A2 Nitric oxide donors, compositions and methods of use
10/23/2003WO2001045641A8 Inhibitors of thrombin induced platelet aggregation
10/23/2003US20030199695 Preparation of 4-(4-flourophenyl)-6-alkyl-2-N-alkansulfonyl-N-alkylamino)pyrimidine-5-carboxylic acid ester.
10/23/2003US20030199694 Thermally stable trimetrexates and processes for producing the same
10/23/2003US20030199560 Bisaryl compound and medicament for cancer treatment comprising the same
10/23/2003US20030199550 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/23/2003US20030199534 Kinase inhibitors
10/23/2003US20030199533 Administering amino, carboxy, alkyl derivatives of barbituric acid to treat diseases of the central nervous system related to the metabotropic glutamate receptor system
10/23/2003US20030199532 2,4-substituted pyrrolidine derivatives-CCR-3 receptor antagonists
10/23/2003US20030199526 Pyrimidine-based compounds useful as GSK-3 inhibitors
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003US20030199446 Stabilizers of DNA to prevent mutations caused by ultriviolet radiation and resulting in skin tumour cells; topical; anticarcinogenic and -tumor agents; sunscreen agents; stabilizers of gene p53 and protein p53
10/23/2003US20030197183 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
10/23/2003CA2481344A1 Inhibitors of glycinamide ribonucleotide transformylase
10/23/2003CA2481240A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003CA2481008A1 Aryl-alkyne compounds as herbicides
10/23/2003CA2480856A1 Substituted aryl amides
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/22/2003EP1354865A1 Process for the preparation of aromatic aldehydes via ozonolysis of aromatic alkenes
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP0927184B1 3-substituted pyrido 4',3':4,5]thieno 2,3-d]pyrimidine derivatives, their preparation and their use
10/22/2003CN1451004A 7-oxo pyridopyrimidines
10/22/2003CN1450996A 2-guanidino-4-aryl-quinazoline
10/22/2003CN1450993A Fungicidal heterocyclic aromatic amides and their compositions methods of use and preparation
10/22/2003CN1450989A 7-substituted tetracycline compounds
10/22/2003CN1125046C Butadiene derivatives and process for preparing thereof
10/21/2003US6635766 Process for the preparation of arylamides of heteroaromatic carboxylic acids
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635651 Inhibitors of thrombin induced platelet aggregation
10/21/2003US6635636 Substituted 6-benzyl-4-oxopyrimidines, process for their preparation and pharmaceutical compositions containing them
10/21/2003US6635630 Respiratory system disorders; antiinflammatory agents
10/21/2003US6635241 Applying aminophenol derivative to keratinous fiber as primary intermediate, oxidizing to color fiber
10/21/2003CA2103894C Aryl sulphonyl urea compounds, a method of preparing them, and their use as herbicides and growth regulators
10/21/2003CA2003480C Fungicides
10/16/2003WO2003084982A2 Functionalized compositions for improved immobilization
10/16/2003WO2003084953A1 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same
10/16/2003WO2003084938A2 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
10/16/2003WO2003084937A2 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases
10/16/2003WO2003084936A2 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
10/16/2003WO2003084935A2 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003084917A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003WO2003070701A3 Syntheses of quinazolinones
10/16/2003WO2003016287A3 Process for preparing 1-(carboxymethyl)- and 1-(aminocarbonyl)- pyrimidin-4-one derivatives
10/16/2003WO2002076939A3 Cysteine protease inhibitors
10/16/2003WO2001066534A3 Cyclic and bicyclic diamino histamine-3 receptor antagonists
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195354 For use as fungicide
10/16/2003US20030195222 Substituted pyrimidinones and pyrimidinthiones
10/16/2003US20030195219 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering cns activity
10/16/2003US20030195211 Inhibitors of human phosphatidylinositol 3-kinase delta
10/16/2003US20030195203 Heterocyclic derivatives
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195195 Substituted pyridines having antiangiogenic activity
10/16/2003US20030195192 Nicotinamides having antiangiogenic activity
1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 427